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Expression of the iron transporter DMT1 in kidney from nor- disease such as hemochromatosis [1, 2]. Therefore, iron
mal and anemic mk mice. homeostasis is tightly regulated and this principally oc-
Background. DMT1 (Nramp2/DCT1) is the major apical curs at the gastrointestinal site of iron uptake, andiron transporter in absorptive cells of the duodenum, but also
through efficient storage [3]. In the serum, iron is tightlytransports transferrin-iron across the membrane of acidified
bound to transferrin and is stored intracellularly com-endosomes in peripheral tissues. DMT1 mRNA and protein
expression has been detected in rat and mouse kidney, but its plexed to ferritin. The current dogma is that there is no
role at that site remains to be clarified. excretion mechanism for iron, with loss from the body
Methods. Immunoblotting and immunohistochemistry with occurring as a result of desquamation and loss of biologi-specific affinity purified anti-DMT1 polyclonal antibodies were
cal fluids.used to study expression and localization of DMT1 in mouse
Proteins responsible for iron acquisition and transportkidney. Possible regulation of DMT1 protein expression by
the body iron stores also was examined in normal mice deprived across cellular membranes have been recently identified,
of dietary iron, and in the genetically anemic mk mice that and their study have provided insight into the regulation
bear a loss of function mutation at DMT1 (G185R).
of the size of body iron stores [4, 5]. One such proteinResults. In microsomal kidney fractions, DMT1 isoform I
is the Divalent Metal Transporter 1 (also known as(encoded by the iron responsive element (IRE)–containing
mRNA) is detected as an abundant 70 to 75 kD membrane Nramp2 and DCT1) [6, 7], a twelve transmembrane do-
protein. DMT1 is expressed in the cortex and not in the me- mains integral membrane protein defining a group of
dulla, and is present at the brush border and apical pole of membrane transporters highly conserved throughout
epithelial cells of proximal tubules. In contrast to the intestine,
evolution [8, 9]. Studies in Xenopus oocytes have shownDMT1 protein expression in kidney is only slightly increased
that DMT1 can transport a number of divalent cationsupon deprivation of dietary iron, suggesting different regula-
tion at the two sites. In kidneys from mk/mk mice, the level including Fe2, Mn2, Zn2 and others [10]. Transport is
of detectable DMT1G185R protein is drastically decreased com- pH-dependent and optimal at acidic pH (5.5 to 6.0),
pared to mk/ controls. electrogenic and associated with proton co-transportConclusion. These results suggest that DMT1 may act as a
[10]. In mammalian cells, DMT1-mediated transport ofre-uptake system for divalent cations at the brush border of
Fe2 and Co2 is saturable (Km 1 mol/L), pH andkidney proximal tubules. A pathological mutation at DMT1
affects targeting/expression of the protein in the kidney. temperature dependent, and into the so-called labile iron
pool [11–13]. Alternative splicing of the DMT1 gene
produces proteins with different C-terminal sequences,
Iron plays an important role in many metabolic path- and different mRNAs that can be distinguished by the
ways acting as a co-factor for key cytoplasmic and mito- presence (isoform I) or absence (isoform II) of an iron
chondrial enzymes. Insufficient amounts of iron result response element (IRE) in the 3 untranslated region
in impaired heme biosynthesis, reduced erythropoietic [14, 15]. Both isoforms I and II have been shown to
output, and ultimately anemia. On the other hand, too be transport competent [10–12, 16]. DMT1 isoform I is
much iron also is deleterious, resulting in iron overload expressed at the brush border of absorptive epithelium
of the duodenum, where it can be drastically up-regu-
lated by deprivation of dietary iron [17]. A mutation
Key words: divalent cations transporter, proximal tubules, brush bor-
(G185R) in TM domain 4 of DMT1 in mk mice [18]der, apical iron transporter, metabolic pathway, anemia, heme biosyn-
thesis. and Belgrade rats [14] causes severe microcytic anemia,
associated with impaired iron uptake at the intestinalReceived for publication August 10, 2001
brush border and in peripheral tissues [19, 20]. Indeed,and in revised form February 12, 2002
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of enterocytes [21]. The DMT1 protein also is expressed mented with 10% fetal calf serum (FCS), 2 mmol/L l-glu-
at high levels in placenta [22], Sertoli cells of the testis (N. tamine, 50 U/mL penicillin and 50 g/mL streptomycin.
Jabado, F. Canonne-Hergaux, and P. Gros; unpublished All media and media supplements were purchased from
observations), and in the brain (substantia nigra and Gibco/BRL (Grand Island, NY, USA). A DMT1 isoform
basal ganglia) [23], suggesting that it may play a key role II cDNA modified by the insertion of an antigenic c-Myc
in iron metabolism in these tissues as well. In addition, epitope at the carboxy terminus [29] was cloned in mam-
DMT1 has been detected in the endosomal/lysosomal malian expression vector pMT2 and introduced in LR73
compartment of different cell types, suggesting that it cells by co-transfection with indicator plasmid pSV2neo
also may participate in transport of transferrin iron [30].
across the membrane of acidified endosomes and into
Crude membrane and cytosolic extractsthe cytoplasm [6, 12, 24].
Finally, RNA expression studies by in situ hybridiza- Crude membrane fractions from cultured CHO cells
tion have identified robust DMT1 mRNA expression in were prepared according to a previously described pro-
the kidney [10]. In our previous immunoblotting studies, cedure [17, 31]. Microsomal fractions from kidneys were
DMT1 protein was detected in kidney microsomal mem- prepared exactly as we have previously described [17].
brane fractions [17]. Interestingly, it was recently sug- Briefly, kidneys were collected, frozen in liquid nitrogen
gested that the kidney plays a role in the homeostasis of and ground to a fine powder using a mortar and pestle
iron and other divalent metals [25], including glomerular cooled with liquid nitrogen and kept on carbonic ice.
filtration of iron and significant subsequent reabsorption Tissues were then homogenized in ice-cold 0.25 mol/L
of the metal [26]. These, together with additional recent sucrose, 0.03 mol/L histine, pH 7.2 (10 mL/g tissues)
studies [27] have suggested that DMT1 may function in supplemented with protease inhibitors [2 mmol/L ethyl-
the kidney as a key reabsorption system for Fe2 and enediaminetetraacetic acid (EDTA), 0.1 mg/mL phenyl-
for other divalent cations. In the present study, we ana- methylsulfonyl fluoride (PMSF), 2 g/mL leupeptin,
lyzed the cellular and sub-cellular DMT1 protein expres- 1 g/mL pepstatin, 2 g/mL aprotinin] using a glass
sion in mouse kidney. The possible regulation of DMT1 potter with a tight-fitting Teflon pestle rotated at 1300
expression in kidney by body iron levels also was investi- revolutions/min. The homogenate was centrifuged at
gated using normal mice placed on a low iron diet and 6000  g for 15 minutes at 4C to eliminate nuclei and
genetically anemic mk/mk mice. intact cells, and membrane fractions were recovered
from the supernatant after centrifugation at 80,000  g
METHODS for 60 minutes at 4C. After ultracentrifugation, the super
natant corresponding to soluble cytosolic proteins wasAnimals
collected and the pellet corresponding to microsomalMK/ReJ-mk/ (Dr. Andrews, Children’s Hospital,
fractions were resuspended in sucrose histidine bufferBoston, MA, USA) were originally obtained from the
supplemented with protease inhibitors. Microsomal frac-Jackson Laboratories, and subsequently maintained as a
tions and soluble cytosolic proteins were stored frozenmk/ heterozygous stock (mk/). Mk/mk homozygotes
at 80C until use. Protein concentration of the variouswere identified in offsprings of an mk/ heterozyogte
membrane fractions was determined by the Bradfordintercross by phenotyping and by genotyping for the
assay (Bio-Rad, Richmond, CA, USA).presence of the Nramp2G185R allele (DMT1G185R), as pre-
viously described [18]. Animals were maintained on a Antibodies
standard rodent diet in the animal facility at McGill
Affinity-purified rabbit polyclonal antibodies directedUniversity. The 129sv mice were initially purchased from
against either the amino terminal (NT; residues 1 to 73)Taconic Farms (Germantown, NY, USA), and subse-
or the carboxy terminal (CT; residues 532-568) segmentsquently maintained as a breeding colony in the Animal
of DMT1 isoform II (non-IRE) were prepared and usedCare Center at McGill University. For the iron depletion
for immunoblotting and immunohistochemistry as pre-experiments, control inbred 129sv mice (DMT1/) were
viously described [17]. Briefly, glutathion-S-transferase-fed either a low iron diet (Fe; ICN, Montreal, Canada)
DMT1-NT or -CT fusion proteins were expressed inor an identical diet supplemented with 3% ferric phos-
Escherichia coli and purified by chromatography on glu-phate (ICN; Fe) for eight weeks before isolation of
tathione-agarose and used as immunogens in rabbits.tissues [17]. Kidneys were removed and either snap-fro-
The polyclonal antiserum was purified by preparativezen in liquid nitrogen for membrane preparations or
immunoblot using the same DMT1 peptide segmentsfixed in Bouin’s solution for immunohistochemistry.
but fused to dihydrofolate reductase (DHFR) [17]. The
Cell culture specificity of the anti-DMT1 antiserum was established
by immunoblotting [17]. Additional antisera directedChinese hamster ovary (CHO) LR73 cells [28] were
grown in -minimal essential medium (MEM) supple- against the transferrin receptor (TfR; CD71; Biosource
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International, Camarillo, CA, USA), the Na/H ex- Five to ten micrometer sections were cut, mounted with
gelatin on glass slides, and immunohistochemical stain-changer-3 (NHE3; Chemicon International, Temecula,
CA, USA), the Na/HCO3- co-transporter (NBC; Chem- ing was performed using the peroxidase-anti-peroxidase
procedure, as previously described [17]. Briefly, sectionsicon), the 1 subunit of the Na/K-ATPase (Upstate
Biotechnology, Argonex Company, Lake Placid, NY, were deparaffinized in xylene and rehydrated in a graded
series of ethanol baths (100%, 95%, 70%, 50%, 30%).USA), and actin (Sigma Chemical Co., St. Louis, MO,
USA) were obtained from commercial sources except Endogenous peroxidase activity in the deparaffinized
sections was blocked with a 1% H2O2 solution in 70% eth-for the anti-H ferritin antibody, which was a generous
gift of Dr. P. Arosio (IRCCS H. San Rafaele, Milano, anol. Sections were then incubated in PBS/100 mmol/L
glycine, rinsed in PBS and blocked for at least one hourItaly).
at room temperature in PBS containing 1% BSA (Frac-
Immunoblot analysis tion V, fatty acid free; Boehringer Mannheim, Mann-
heim, Germany), 5% heat-inactivated normal goat se-Crude membrane preparations from tissues (80 g),
CHO cells (5 g) or soluble cytosolic proteins (30 g) rum (Gibco), and 5% heat-inactivated normal mouse
serum. Incubation with the primary antibody diluted inwere separated by sodium dodecylsulfate polyacryl-
amide gel electrophoresis (SDS-PAGE; 10% polyacryl- blocking solution was carried out in a wet chamber 16
hours at 4C. Dilution of antibodies were as follows: anti-amide) and transferred by electroblotting to polyvinyli-
dene fluoride membrane (PVDF; 16 hours at 4C). For DMT1-NT (1/20 to 1/40), anti-DMT1-CT (1/20 to 1/40),
non-immune serum (NIS; 1/20 to 1/40), anti-NHE3all detection using microsomal membranes, samples
were incubated 30 minutes at room temperature in 1 (1/100) and anti-NBC (1/500). Following incubation with
the primary antibody, three washes in PBS, and incuba-Laemmli sample buffer (with occasional vortexing) prior
to SDS-PAGE (boiling of samples was found to cause tion with the secondary antibody (swine anti-rabbit IgG,
1:100; Dako, Carpinteria, CA, USA), subsequent rabbitaggregation of DMT1 protein). For ferritin and actin
detection, soluble cytosolic proteins samples in 1 peroxidase-anti-peroxidase immunostaining (PAP, 1:100;
Dako) was revealed using 3-diaminobenzidine tetrahy-Laemmli buffer were boiled for five minutes prior SDS-
PAGE. Similar loading on gel and similar transfer of drochloride (DAB) in solution. Sections were then coun-
terstained with 0.1% methylene blue in PBS. Finally,proteins to the membrane was verified by staining the
blots with Ponceau S Red (Sigma). Immunoblots were sections were dehydrated again in ethanol and xylene
and mounted in Permount. Immunostaining was ana-pre-incubated with blocking solution (0.02% Tween 20,
7% skim milk in PBS) two hours at 20C or O/N at lyzed with a Nikon microscope using 10 dry objective,
40 and 100 oil immersion objective.4C, followed by incubation with primary antibodies (16
hours at 4C for anti-DMT1 and one hour 30 min at
20C for other antibodies) in blocking solution. Primary
RESULTS
antibodies were used as follows: rabbit anti-mouse
Expression and localization of DMT1/Nramp2 inDMT1-NT (1/200), rat anti-mouse TfR (1/500), rabbit
normal kidneyanti-rat NBC (1/10,000), rabbit anti-rat Na,K-ATPase
(1/1000), rabbit anti-mouse actin (1/1000) and a rabbit Using a rabbit antiserum (DMT1-NT), in kidney mi-
crosomal membranes, DMT1 is expressed as a broadanti-mouse H ferritin (1/2000). Membranes were washed
[phosphate buffered saline (PBS)  0.2% Tween 20] immunoreactive species of molecular mass 70 to 75 kD
with a major polypeptide band at 70 kD at low exposurefollowed by incubation with either peroxidase labeled
anti-rat, or anti-rabbit or anti-mouse secondary antibod- time (Fig. 1). The electrophoretic mobility of DMT1
detected in kidney is faster than that seen in the DMT1-ies (1/10,000; 1 hour at 20C; Amersham, Ontario,
Canada), and the signal was visualized by Enhanced transfected CHO cells (80 to 100 kD) used as controls
(Fig. 1), suggesting possible differences in post-transla-ChemiLuminescence (ECL; Amersham). In certain ex-
periments, membranes were stripped (100 mmol/L 	2- tional modification of the two proteins. Additional con-
trol experiments using an isoform-specific anti-DMT1mercaptoethanol, 2% SDS, 62.5 mmol/L Tris-HCl pH
6.8; 50C for 30 min) and then reprobed with a different antiserum directed against the non-IRE isoform II
(DMT1-CT), indicated that it is the IRE-containing iso-primary antibody.
form I that is expressed in kidney (Fig. 3).
Immunohistochemistry The organ distribution, cellular and subcellular local-
ization of DMT1 protein in kidney was next investigatedAfter fixation in Bouin’s solution (picric acid 9 g/L,
acetic acid 4% and formaldehyde 25%) for 72 hours at by immunohistochemistry. Examination of kidney sec-
tions at low magnification (10) revealed obvious DMT120C, kidneys were dehydrated in a series of ethanol
(3  20 min: 70%, 95%, 100%), ethanol/xylene (1/1) positive staining in the cortex (Fig. 2A), and that was
absent from control sections similarly incubated withand xylene solutions, followed by embedding in paraffin.
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lumen of proximal tubule cells, a possibility that was
further explored by parallel staining with a control anti-
serum directed against the BB-specific marker NHE3
(Fig. 3E). NHE3 staining was strikingly similar to that
seen with DMT1 in cortical sections and concentrated
in the luminal surface of proximal epithelial cells. By
contrast, DMT1 staining was clearly distinct from that
produced by antibodies directed against NaHCO3 co-
transporter (NBC), a protein expressed at the basolateral
membrane of kidney tubules (Fig. 3F). Finally, positive
staining of kidney cortical sections was only observed
with our DMT1-NT (isoforms I and II; Fig. 3 A-C) antise-
rum but not with our anti-DMT1-CT (isoform II specific;
Fig. 3D), suggesting that the large majority of DMT1
Fig. 1. Immunoblotting detection of DMT1 protein in kidney. Kidney expressed in kidney is the IRE-containing isoform I.
microsomal fractions (80 g) from wild type mice were resolved on a
10% acrylamide gel, transferred to a PVDF membrane and analyzed by Effect of iron status on DMT1 expression in kidneyimmunoblotting using an affinity-purified rabbit anti-DMT1 polyclonal
antiserum (DMT1-NT; [17, 21]) directed against the amino terminus of Because the IRE-containing isoform I of DMT1 is the
the protein. To control the specificity of the antibody, 5 g of membrane isoform predominantly expressed in kidney, and becausefractions prepared from control Chinese hamster ovary cells (CHO),
protein expression of isoform I is strongly regulated byand from CHO transfectants overexpressing DMT1 (CHO-DMT1)
were included. The size of the molecular mass markers (in kD) is dietary iron in the duodenum, the effect of iron status
indicated at the right of the blot, and the major immunoreactive DMT1 on kidney DMT1 expression was investigated. The re-protein (70kD) is indicated by an empty arrowhead.
sults from two independent experiments are shown in
Figure 4 for two different groups of mice. Iron depriva-
tion was associated with atwofold (estimated by densi-
tometry) increase in DMT1 protein expression in kidneypre-immune serum (Fig. 2B). In the cortex, staining was
not uniform, but heterogeneous and appeared limited membranes (Fig. 4 A1, B1). The iron deprivation status
of experimental animals was verified by increased ex-to certain tubular elements while others did not stain (see
below). The medulla was negative for DMT1 staining pression of TfR (Fig. 4 B2) and strong decreased expres-
sion of H-ferritin (Fig. 4 B3), which were used as controls.suggesting that medullar structures such as the distal
portions of ascending and descending loops of Henle, Equal loading of proteins on gel and equal transfer to
the blotting membrane were verified by similar signalsand the small and large collecting ducts do not express
DMT1. Analysis of cortical images at 40 magnification obtained with antibodies directed against the NBC (A2),
Na,K-ATPase (1 subunit) (A3), and actin (B4) thatconfirmed that that DMT1 staining was restricted to a
subset of tubular structures, with additional tubules ei- were used as negative controls in these experiments.
These results suggest a modest increase of DMT1 expres-ther interspersed or clustered together being negative
for staining; identifiable blood vessels and glomeruli also sion in kidney in response to iron deprivation.
appeared negative for staining (Fig. 2D). At highest mag-
DMT1 expression in kidneys from anemicnification (100; Fig. 3 A, B and C), the tubules positive
mk/mk micefor DMT1 present a taller epithelium and a much smaller
luminal space than adjacent tubules that did not stain To further explore a possible contribution of DMT1 in
the kidney to the regulation of iron homeostasis, DMT1for DMT1. Staining in positive tubules was clearly con-
centrated to the apical pole of epithelial cells and/or to protein expression was examined in the microcytic ane-
mia mk mouse mutant showing a profound defect in ironthe luminal space of the tubule itself (arrows), and was
detected as an intense but diffuse staining. In some sec- metabolism. By immunoblotting, a dramatic decrease in
the level of expression of DMT1 by a factor of 6- to 50-tions (Fig. 3A and data not shown), light staining can be
also seen in the cytoplasm of epithelial cells. Identifiable fold (estimated by densitometry) was noted consistently
in kidney membranes from mk/mk mice when comparedglomeruli and other tubular structures were negative
for DMT1. The morphological appearance of tubules to mk/ controls (Fig. 5). Such low DMT1 protein ex-
pression was found in independent membrane prepara-positive for DMT1 (epithelial and luminal characteris-
tics) and their localization in the cortex suggested that tions of mk/mk kidneys, and in different mk/mk indiv-
iduals (data not shown). Equal loading on gel forthey were proximal tubules (PT), with distal tubules
(DT) negative for DMT1 protein expression. Further- SDS-PAGE, and equal transfer to blotting membrane
for immunoblotting was verified by detection of the NBCmore, DMT1 appeared concentrated to a prominent
brush border (BB) (tall microvilli) projecting into the (Fig. 5C), and Na,K-ATPase (1 subunit; Fig. 5D) as
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Fig. 2. Immunohistochemical staining of
DMT1 protein in the kidney. Kidney tissue
sections prepared as described in the Methods
section, were stained with polyclonal rabbit
anti-DMT1 antiserum (DMT1-NT) directed
against the amino terminus of the protein (A,
C and D) or normal rabbit pre-immune serum
(B). From 4 distinct animals, 8 to 12 indepen-
dent immunodetections were performed. Sec-
tions were counterstained with methylene
blue, before microscopic examination and
photography. Low (10; A and B) and me-
dium (40; C and D) magnification of histo-
logical sections of kidney cortex from normal
mice are shown. The cortex (C) and medulla
(M) portions of the kidney are identified.
Fig. 3. Immunohistochemical staining of
DMT1 protein in the kidney. Kidney tissue
sections A, B, and C (from three independent
animals) were stained with the polyclonal rab-
bit anti-DMT1 antiserum (DMT1-NT) di-
rected against the amino terminus of the pro-
tein; panel D section (from one animal used
in C) was stained with an isoform specific anti-
DMT1 antiserum directed against the C-ter-
minal region (DMT1-CT) of the non-IRE
DMT1 isoform (isoform II). Panels E and F
(sections from one animal) were stained with
antisera directed against the Na/H ex-
changer isoform 3 (NHE3; E), and against the
NaHCO3 co-transporter (NBC; F), which
were used as specific markers of the brush
border and of the basolateral membrane, re-
spectively. All sections were examined and
photographed at high magnification (100).
Glomeruli (GM), proximal tubules (PT), dis-
tal tubules (DT), brush border (BB) and baso-
lateral (BL) membranes are identified.
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Fig. 4. Effect of dietary iron deprivation on
DMT1 expression in kidney. Kidney micro-
somal fractions and soluble cytosolic proteins
were prepared from animals fed either a nor-
mal (Fe) or a iron-deprived (Fe) diet. Im-
munoblots (see legend to Fig. 1) from two
independent experiments (A and B) were ana-
lyzed with anti-DMT1 antiserum directed
against the amino terminus of the protein
(DMT1-NT; frames A1 and A2). In panel A,
control antisera directed against the NBC (2),
and against the 1 subunit of Na,K-ATPase
(3) were used as controls. In panel B, control
antisera directed against the TfR (2), ferritin
(3), and actin (4) were used as controls. All
immunoblots consisted of 80g of microsomal
fractions, except for frames 3 and 4 of panel
B, which were with 30 g of soluble cytosolic
fractions. Membranes from CHO and CHO-
DMT1 transfected cells were used as negative
and positive controls, respectively. The size of
the molecular mass markers (in kD) is indi-
cated at the right of the blots.
negative controls, while presence of anemic status in DMT1 may be post-translationally modified by glycosyl-
ation, a proposal compatible with the diffuse appearancethe kidney was associated with elevated levels of TfR
expression (Fig. 5B). Parallel studies by immunohisto- of the immunoreactive band on immunoblots, and con-
sistent with our previous biochemical studies in DMT1-chemistry of mk/mk kidney sections using the anti-
DMT1-NT antiserum likewise failed to detect any sig- transfected cells [6]. Interestingly, the DMT1 protein
expressed at the BB of intestinal epithelial cells also isnificant staining, including the BB of proximal tubules
(data not shown). Together, these results suggest that likely glycosylated but it shows a higher molecular mass
(80 to 90 kD) than the form expressed in kidney cells.DMT1 protein expression is either actively repressed in
kidneys of mk/mk mice, or that the DMT1G185R variant Therefore, it appears that heterogeneity in post-transla-
tional modification such as glycosylation may exist inproduces a protein that is unstable and/or inappropri-
different cell types.ately targeted to the BB of proximal tubules.
In kidney sections, DMT1 was expressed only in a
population of tubular structures in the cortex, while the
DISCUSSION rest of the kidney including the medulla did not express
The tissue, cellular and subcellular localization of the DMT1. We have assigned the DMT1-positive tubule
DMT1 protein in kidney was studied by immunoblotting population as proximal tubules, based on the following
and by immunohistochemistry, using an affinity-purified criteria. Firstly, the cortex contains a number of tubular
antiserum directed against the amino terminus of the structures (such as, proximal, distal), and blood vessels
protein. The specificity of this antiserum for DMT1 has with proximal tubules being predominant outside medul-
been established in transfected and primary cell lines lary rays; DMT1 positive tubules were the most abundant
[6, 17] and has been used to localize DMT1 in the intes- in cortex. Secondly, DMT1 positive tubules had a taller
tine [17]. In kidney, DMT1 was expressed as a major 70 epithelium and much narrower lumen (when distinguish-
to 75 kD species, a size similar to the form expressed in able) than the DMT1-negative tubules in the same sec-
rat kidney [27]. This size is larger than that predicted tions, two known morphological distinctions between
proximal and distal tubules, respectively [32]. Thirdly,from the primary sequence (62.3 kD), suggesting that
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express DMT1 or express amounts that are not detect-
able by our antiserum. Abundant DMT1 protein expres-
sion in proximal tubules detected here is consistent with
the identification of proximal tubules as the most promi-
nent site of DMT1 mRNA expression detected by in situ
hybridization in normal rat kidneys [10].
The staining pattern of DMT1 in kidney sections re-
ported here is different from that recently reported by
Ferguson et al [27]. Using a rabbit antiserum directed
against a synthetic N-terminal peptide of DMT1, these
authors observed, as we did, strong cortical staining.
However, in proximal tubules, staining was intracellular
with no staining at the BB, in sharp contrast to our
results. They also reported punctuate staining at the api-
cal membrane and cytoplasmic staining in thick as-
cending limbs, as well as apical staining in distal convo-
luted tubules, and in outer medullary and cortical
collecting ducts [27]. The reasons underlying the differ-
ent DMT1 staining patterns in the two studies, with re-
spect to sub-cellular localization and positive tubules
populations (for example, distal tubules and collecting
ducts), remain unclear at this time. However, they may
reflect the analysis of tissues from different species
(mouse vs. rat), or may be caused by the use of different
antibodies of different avidity and specificity that are
directed against overlapping but different DMT1 epi-
topes. Moreover, differences in tissue collection, prepa-
ration, fixation and analysis may have contributed to
observed differences in staining profiles. Finally, intra-
cellular staining of DMT1 in rat tubules [27] versus BB
staining in mouse proximal tubules (our current study)
may reflect different steps in a common trafficking path-
way between internal compartments and the plasma
membrane.
We have previously reported abundant expression ofFig. 5. DMT1 expression in kidney of mk/mk mice. Kidney microsomal
DMT1 protein at the BB of the intestine, where it isfractions were prepared from either normal mk/ controls, or from
mk/mk microcytic anemia mice (4 animals in each group). The immu- responsible for active transport of Fe2 from the luminal
noblots were analyzed with the anti-DMT1 antiserum directed against space into enterocytes [17]. The noted expression ofthe amino terminus of the protein (DMT1-NT; A), and with antibodies
DMT1 at the BB of the kidney proximal tubules suggestsdirected against the TfR (B), the NBC (C), and the 1 subunit of
Na,K-ATPase (D), which were used as controls. Membranes from that it may play a similar role at that site, in this case
CHO and CHO-DMT1 transfected cells were used as negative and transporting Fe2 or other divalent cations from the lumi-positive controls, respectively. The size of the molecular mass markers
nal filtrate into the epithelial cells, as a re-absorption(in kD) is indicated at the right of the blots.
system. Such a re-absorption system for Fe2 has recently
been detected in rat kidney by microinjection and mi-
croperfusion techniques, and was found to be most active
DMT1 staining was “fuzzy” and most intense at the lumi- in the loop of Henle [26]. Experiments in Xenopus oo-
nal surface of the tubule. This staining pattern was strik- cytes [10] and in transfected CHO cells expressing DMT1
ingly similar to that of NHE3, a marker of the brush at the plasma membrane [11] have shown that DMT1-
border specific to the epithelium of proximal tubules mediated transport of divalent cations is strictly pH-
[33, 34]. At this point, we cannot establish with certainty dependent, is most active at acidic pH of 5.5 to 6.5, and
which portion(s) (convoluted or straight) if not all of the seems to involve co-transport of a single H. Therefore,
proximal tubule is positive for DMT1. However, our it is likely that DMT1 transport at the BB of the proximal
results suggest that more distal kidney tubules, including tubule is also pH-dependent. In both the convoluted and
descending and ascending portions of the loop of Henle, straight portions of the proximal tubule, the pH of the
filtrate drops by one pH unit (from pH 7.6 to pH 6.7)distal convoluted tubules, and collecting ducts do not
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[35, 36] that results in reabsorption of approximately effect on the level of DMT1 expression in kidney (data
70% of the available HCO3 . This is due to the active not shown) and intestine [39]. In addition, other protein
secretion of protons in the luminal space through the involved in iron metabolism such as TfR or ferroportin
action of the Na/H exchanger principally, and also by 1 also are expressed in the kidney [40, 41]. Therefore, the
the H/ATPase, expressed at the brush border and in relative contribution of DMT1 to tubular reabsorption of
the endosomal compartment of epithelial cells lining the iron remains to be established and must be considered
tubule, respectively [34–36]. Therefore, the acidic pH of with respect to other iron transport systems such as TfR
the filtrate present in the proximal tubule is compatible and ferroportin 1.
with the known requirements for divalent cations trans- Nevertheless, kidney DMT1 may be a valid therapeu-
port by DMT1. Downstream the proximal tubule, there tic target for drug design and pharmacological interven-
is a modest alkalinization of the filtrate in the loop of tion in iron overload diseases, such as hereditary hemo-
Henle (up to pH7.4), before progressive re-acidification chromatosis as originally suggested by Ferguson et al
in distal tubules and collecting ducts to reach a final pH [27]. Indeed, blocking DMT1 action with a small mole-
of 6.0 [35, 36]. Therefore, the pH of the distal tubules cule inhibitor may achieve both reduced iron uptake at
and downstream collecting ducts also could support diva- the intestine, and more importantly, reduced re-absorp-
lent cation transport by DMT1, should it be present at tion in the kidney and thus increased secretion of iron
that site. into the urine.
The kidney DMT1 isoform is recognized by a generic Finally, it has been proposed that iron plays an impor-
anti-DMT1 antiserum directed against the amino termi- tant role in the pathophysiology of renal disease, through
nus of DMT1, which is identical in both isoforms of the the local generation of reactive oxygen species [42]. In
protein (I and II). However, an isoform II-specific (non- animal and human nephrotic syndromes, iron accumula-
IRE containing) antiserum (DMT1-CT) does not react tion occurs primarily in proximal tubular cells and more
with the kidney DMT1 isoform, strongly suggesting that precisely in lysosomes [43–45]. Proteinuria has been
it is the IRE-containing isoform I expressed in kidney. evoked as a cause of tubulointerstitial injury and one
At the intestinal mucosa, DMT1 isoform I is regulated urinary protein of interest is holotransferrin (Tf-Fe),
by dietary iron, and is dramatically induced in normal which can be excreted in large amounts in the tubular
animals when fed a low iron diet, possibly through regu- fluid of nephrotic patients [46]. In vivo and in vitro stud-
lation by the IRE/IRP regulatory network [17]. This ies have indicated the nephrotoxicity of Tf-Fe, and holo-
prompted us to analyze DMT1 expression in kidney from transferrin was shown to be toxic to proximal tubules
animals similarly deprived of dietary iron. By immu- cells in a pH-dependent effect [47]. The characteristic
noblotting, we did detect a modest but reproducible
of DMT1-mediated iron transport and the localization of
increase in DMT1 expression in kidney microsomal
DMT1 to the brush border (this study) and intracellularmembranes. These results are in agreement with the
space [27] of proximal tubular cells are consistent withhypothesis that iron deprivation results in increased
the proposal that DMT1 may be associated to iron-DMT1 expression at the brush border in the kidney,
induced toxicity in kidney observed in nephrotic syn-possibly to prevent any loss of precious iron in the urine
drome.in time of great demand. However, the modest increase
An interesting finding was the considerable reductionnoted in kidney compared to the massive overexpression
of DMT1 protein detected in kidney from mk/mk mice,seen in the intestine of similarly iron-deprived animals
homozygous for the DMT1G185R mutation. Importantly,suggests caution in such an interpretation. In addition,
reduced DMT1G185R protein expression also was notedthe different behavior of the IRE-containing isoform I
in other tissues from mk/mk mice (notably liver andof DMT1 in kidney and intestinal BB following depriva-
spleen as well as in erythroid cell precursors) when com-tion of dietary iron, suggests different regulatory net-
pared to control wild type or mk/ heterozygotes ([48];works in the two tissues; such regulatory mechanisms
our unpublished observations). On the other hand, con-remain to be characterized. Interestingly, kidney DMT1
trasting with these observations, we previously reporteddid not appear to respond to the so-called “erythroid
a strong up-regulation of the same isoform I in the duo-iron regulator” [3], as animals exposed to stimuli known
denum of mk mouse model [21]. However, the targetingto induce erythropoiesis (exposure to phenylhydrazine,
of the mutant protein to its site of action, the brush bor-treatment with erythropoietin) did not affect DMT1 ex-
der of enterocytes, is dramatically impaired in mk/mkpression levels (data not shown). Therefore, DMT1 may
intestine [21]. Therefore, the G185R mutation may leadact in the kidney as a “salvage” pathway for iron and
to mistargeting of the protein in duodenum and/or degra-possibly other divalent metals. Finally, a null mutation
dation of the protein in other tissues such as kidney,at the mouse homolog of the HFE gene (mutated in
liver, spleen and erythroid precursors [48]. In addition,hemochromatosis patients [37]) causes massive iron
overload in the liver of these mice [38], but was without potential iron-dependent regulatory mechanisms aimed
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